Options expiring 23 Dec 2022 Ex at $0.20 for 10m shares. Not a small amount of money the company would really want to add to the Balance Sheet. I wonder if we'll see a little mid December announcement to push them safely into the money or if they'll lapse?
Don't think it will be Phase 3 EMD-RX5 trial results, too early in my opinion. Maybe a partner coming on board for commercial fun and games? Idle speculation of course, but be nice to think they have something in the works to get these up.
Add to My Watchlist
What is My Watchlist?
